JNJ-32729463

· Johnson & Johnson

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JNJ-32729463, covering 2011-12-08 to 2011-12-16. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of JNJ-32729463 for Treating Complicated Skin and Skin Structure Infections Compared to Linezolid (Zyvox) [Phase 2]

See pricing